Vanda Pharmaceuticals reported $61.41M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Akebia Therapeutics AKBA:US USD 98.04M 5.19M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Anika Therapeutics ANIK:US USD 28.58M 14.46M
Arrowhead Research ARWR:US USD 115.4M 10.08M
AstraZeneca AZN:LN USD 9.74B 495M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Clovis Oncology CLVS:US USD 74.9M 16.63M
Eli Lilly And LLY:US USD 5.47B 200.3M
Enanta Pharmaceuticals ENTA:US USD 47.36M 4.65M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Insmed INSM:US USD 195.43M 41.89M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Lexicon Pharmaceuticals LXRX:US USD -23134000 47.18M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Merk MRK:US USD 10.32B 624M
Minerva Neurosciences NERV:US USD 5.21M 1.76M
Moderna Inc MRNA:US USD 2.2B 104M
Novartis NVS:US USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Puma Biotechnology PBYI:US USD 54.71M 7.19M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Takeda 4502:JP JPY 949.56B 51.69B
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Vanda Pharmaceuticals VNDA:US USD 61.41M 481K
Veracyte VCYT:US USD 85.27M 1.67M